Mask-Related Motion Artifact on 99mTc-MIBI SPECT: Unexpected Pitfalls of SARS-CoV-2 Countermeasures

Purpose As COVID-19 was uncovered, it became evident that specific individuals could experience multi-organ complications for quite a while after infection. Among them, there were several cardiovascular complications. Myocardial perfusion imaging single photon emission computed tomography (MPI SPECT) can be utilized to detect and evaluate cardiac problems regardless of whether COVID caused them. By examining all publications relevant to the impacts of the pandemic on SPECT MPI imaging, we aimed to understand how the COVID pandemic affected different aspects of the MPI, how intense these effects were, and what the consequences were. Method On the 6th of June, 2022, a four-domain search strategy was developed and implemented by searching the following databases: PubMed, SCOPUS, EMBASE, Web of Science, and the Cochrane Central Register of Controlled Trials. The retrieved records have been put through two levels of screening. The search for forward and backward citations provided more results. Results This study contained 32 papers, divided into the following three categories: 1. Case reports and series; 2. A comparison of the number of MPIs conducted before and after the pandemic; and 3. SPECT MPI findings. Conclusion We observed through the article review that CT scans performed in combination with MPI are crucial and should be interpreted within the context of COVID, especially during outbreaks. Moreover, we discovered that in the initial months of the pandemic, the number of SPECT MPIs performed globally decreased, with the fall being more significant in some countries, primarily in low- to middle-income regions. Lastly, we found that individuals with a history of COVID-19 may be more prone to having MPIs that demonstrate abnormalities, such as ischemia. Graphical abstract

show abstract

“…An occupational physician referred patient 7 [ 31 ] for the exclusion of CAD. On his initial electrocardiogram, LBBB was detected.…”

Section: Resultsmentioning

confidence: 99%

Myocardial perfusion imaging in the era of COVID-19: a systematic review

Hassanzadeh

Neshat

Heidari

et al. 2022

Clin Transl Imaging

View full text Add to dashboard Cite

show abstract

“…According to our results and other studies’ findings, more than 28% of COVID-19-infected patients exhibit signs of cardiac injury. This is associated with a poor prognosis, a sore throat, a newly developed loss of taste or smell, fever, chills, bone and muscle pain, and other symptoms 22 – 24 .…”

Section: Discussionmentioning

confidence: 99%

The effect of COVID-19 on nuclear medicine and radiopharmacy activities: A global survey

Al-Saeedi

Rajendran

Tipre

et al. 2023

Sci Rep

View full text Add to dashboard Cite

Globally, COVID-19 affected radiopharmaceutical laboratories. This study sought to determine the economic, service, and research impacts of COVID-19 on radiopharmacy. This online survey was conducted with the participation of employees from nuclear medicine and radiopharmaceutical companies. The socioeconomic status of the individuals was collected. The study was participated by 145 medical professionals from 25 different countries. From this work, it is evident that 2-deoxy-2-[18F]fluoro-D-glucose (2-[18F]FDG), and 99mTc-labeled macro aggregated albumin 99mTc-MAA were necessary radiopharmaceuticals used by 57% (83/145and 34% (49/145;) respondents, respectively for determining how COVID infections affect a patient’s body. The normal scheduling procedure for the radiopharmacy laboratory was reduced by more than half (65%; 94/145). In COVID-19, 70% (102/145) of respondents followed the regulations established by the local departments. Throughout the pandemic, there was a 97% (141/145) decrease in all staffing recruitment efforts. The field of nuclear medicine research, as well as the radiopharmaceutical industry, were both adversely affected by COVID-19.

show abstract

“…Also, people responded differently to COVID-19, which is re ected by the different needs and uses of radiopharmaceuticals. Myocardial radiopharmaceuticals also were used during the pandemic to rule out the cause of these symptoms (Cichocki et al 2021). More than 7-28% of patients infected with COVID-19 have evidence of cardiac injury related to adverse prognosis (Alam et al 2021;Singh et al 2021).…”

Section: Discussionmentioning

confidence: 99%

The Impact Of COVID-19 Pandemic On The Radiopharmacy Activities National And International Survey, The Standard Is Missing

Al-Saeedi

Rajendran

Tipre

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: The COVID–19 pandemic is confronting the business activities of radiopharmaceutical labs globally. This study aimed to find out the impact of COVID–19 on the radiopharmacy business, services, and research activities. Methods: This survey was conducted online among nuclear medicine and radiopharmaceutical staff. Results: Socio-demographic information was collected. A total of 140 health professionals from 23 countries participated in the study. We observed that the 18F–fluorodeoxyglucose was used frequently during COVID–19 pandemic. The radiopharmacy lab scheduling was reduced. The majority of the respondents were using the local departmental regulations. Conclusions: COVID–19 adversely affected the radiopharmaceutical business and nuclear medicine research.

show abstract

Mask-Related Motion Artifact on 99mTc-MIBI SPECT: Unexpected Pitfalls of SARS-CoV-2 Countermeasures

Cited by 4 publications

References 5 publications

Myocardial perfusion imaging in the era of COVID-19: a systematic review

Myocardial perfusion imaging in the era of COVID-19: a systematic review

The effect of COVID-19 on nuclear medicine and radiopharmacy activities: A global survey

The Impact Of COVID-19 Pandemic On The Radiopharmacy Activities National And International Survey, The Standard Is Missing

Contact Info

Product

Resources

About